Latest Regulated Industries News

IDT Australia reports a sharp turnaround in FY26 with a 66% reduction in net loss and an 85% improvement in EBITDA, underpinned by a strategic reset and targeted investments in manufacturing capabilities.

Stakk Ltd's combined pro forma FY2026 revenue with ParaScript has climbed to approximately A$45 million, surpassing earlier forecasts by 9%. Both companies outperformed initial revenue assumptions, setting a stronger baseline ahead of integration benefits.

Stakk Limited is set to become a global powerhouse in AI-driven Digital Trust infrastructure following its US$63 million acquisition of ParaScript, a leader in AI-powered document intelligence and fraud detection. The deal significantly boosts Stakk's scale, technology, and recurring revenue base, underpinning a robust growth trajectory.

Stakk Ltd anticipates its first operating profit in FY2026, driven by a surge in recurring revenue and major contract wins, with FY2027 revenue projected at $21.8 million based on existing agreements.

WhiteHawk Limited has forged a strategic alliance with Perth-based Adisyn Services to enhance cyber risk management and compliance solutions tailored for the defence sector, focusing on AUKUS programs and supply chain security.

Stakk Ltd has secured a significant U.S. healthcare technology contract, pushing its annualised revenue run rate to approximately A$26 million. The deal highlights accelerating adoption of its AI-native Digital Trust platform across regulated industries.

Pro Medicus secures a $16 million, 7-year cloud imaging contract with TidalHealth, complementing recent major wins and contract renewals that underscore its growing dominance in North American healthcare IT.

WhiteHawk has secured Atturra as its first Australian enterprise partner for the Quixxi Clarity AI platform, aiming to accelerate AI governance adoption across government and enterprise sectors.

Stakk Ltd has reported a striking 186% quarter-on-quarter revenue jump to A$5.52 million in Q1 2026, driven by converting contracted clients into active billing and new engagements, underpinning strong recurring revenue and cash flow.

Stakk Ltd (ASX: SKK) has delivered a striking 272% jump in gross receipts to $5.36 million in Q3 FY26, reversing prior cash outflows with a positive net cash flow of $2.25 million and closing the quarter with $17.34 million in cash.

Bioxyne Ltd has secured a manufacturing agreement with global cannabis giant Aurora Cannabis, marking a major step in its international expansion of pharmaceutical-grade medicinal cannabis products.

Stakk Limited’s U.S. subsidiary has landed its largest-ever contract worth A$7.85 million, marking a significant step in expanding its AI-native trust infrastructure across regulated industries including healthcare.